Ferdinandus, J., Kaul, H., Fosså, A., Hüttmann, A., Keil, F., Ko, Y., Hitz, F., Schwarz, M., Trenker, C., Kerkhoff, A., Staib, P., Wille, K., Dresel, I., Hahn, D., Hertenstein, B., Moosmann, P., Mey, U., Balabanov, S., Armytage, T., Roncolato, F., Hellmuth, J. C., Hertzberg, M., Kobe, C., Klapper, W., Baues, C., Eich, H., Kreissl, S., Fuchs, M., Jablonski, J., Schneider, G., Tharmaseelan, H., Eichenauer, D. A., Tresckow, B. V., Borchmann, P., Bröckelmann, P. J. (2025). Positron Emission Tomography–Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00439